Craniomaxillofacial implants refers to implants used in the Craniomaxillofacial surgeries. Craniomaxillofacial surgery is performed to treat injuries, defects, and diseases in the head, neck, face, jaws, hard and soft tissues of the oral and maxillofacial region.
It is internationally recognized surgical speciality. The major factors driving the growth of this market are increasing number of road accidents, trauma cases, rising demand for minimally invasive reconstruction surgeries, rising prevalence of congenital facial deformities, and technological advancements.
Download FREE Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=43426581
High growth potential in emerging markets have opened an array of opportunities for the market. On the other hand, high cost of craniomaxillofacial surgeries is a major factor expected to restrain the growth of this market during the forecast period.
The global market is broadly classified into type, application site, material of construction, property and regions.
The global craniomaxillofacial implants market is expected to reach $2.49 Billion by 2021 from $1.79 Billion in 2016 at a CAGR of 6.9% from 2016 to 2021.
The key players in the craniomaxillofacial implants market are Stryker (U.S.), KLS Martin (U.S.), Depuy Synthes (U.S.)., Zimmer Biomet (U.S.), Medtronic (Ireland), Integra Lifesciences (U.S.), OsteoMed (U.S.), Medartis AG (Switzerland), Matrix Surgical USA (U.S.), and Calavera (U.S.)
To Know More @
https://www.marketsandmarkets.com/Market-Reports/craniomaxillofacial-implant-market-43426581.html
